Journal of the American Society of Nephrology

A Microsimulation of Eligibility for Cardiorenal Combination Treatment and Potential Deaths Averted

By Massimo Nardone, Labib Faruque, Lisa Dubrofsky, Ayodele Odutayo

Computational studyInterventions

The paper

University Health Network; Sunnybrook Health Sciences Centre

Journal of the American Society of Nephrology, 9 Oct 2026

doi.org/10.1681/asn.0000001287 PubMed 42853614

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease